Pharmacokinetics of progesterone in postmenopausal women: 1. Pharmacokinetics following intravaginal administration

European Journal of Drug Metabolism and Pharmacokinetics

Volumn 23, Issue 3, 1998, Pages 391-396

  Mircioiu, C ^a   Perju, A ^a   Neagu, A ^a   Griu, E ^a   Calin, G ^a   Miron, D S ^a  

^a CAROL DAVILA UNIVERSITY OF MEDICINE AND PHARMACY   (Romania)

Author keywords

Pharmacokinetics; Progesterone; Vaginal suppositories

Indexed keywords

GESTAGEN; PROGESTERONE;

AREA UNDER THE CURVE; ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DRUG ABSORPTION; DRUG ELIMINATION; DRUG HALF LIFE; DRUG RELEASE; EMULSION; FEMALE; HUMAN; HUMAN EXPERIMENT; HYDROPHOBICITY; INTRAVAGINAL DRUG ADMINISTRATION; NORMAL HUMAN; POSTMENOPAUSE; PROGESTERONE BLOOD LEVEL; RADIOIMMUNOASSAY;

ADMINISTRATION, INTRAVAGINAL; AREA UNDER CURVE; BIOLOGICAL AVAILABILITY; DOSE-RESPONSE RELATIONSHIP, DRUG; EMULSIONS; FEMALE; HUMANS; METABOLIC CLEARANCE RATE; MODELS, BIOLOGICAL; POSTMENOPAUSE; PROGESTERONE; STATISTICS; SUPPOSITORIES;

EID: 0031796036     PISSN: 03787966     EISSN: None     Source Type: Journal    
DOI: 10.1007/BF03192299     Document Type: Article

References (21)

1. Check J.H., Rankin A., Teichman M. (1986) : The risk of fetal anomalies as a result of progesterone therapy during pregnancy. Fertil. Steril., 45, 575-577.
2. Lobo R.A., Whithead M.I. (Eds) 1989 : Proceedings of the consensus development conference on progesterone. New York: Worldwide Medical Group.
3. Morville R., Dray F., Reynier J., Barrat J. (1982) : Biodisponibilité de la progesterone naturelle administrée par voie orale. J. Gynecol. Obstet. Biol. Reprod., 11, 355-363.
4. Ottosson U.B., Carlstrom K., Damber J.E., Von Schoultz B. (1984) : Serum levels of progesterone and some of its metabolites including deoxycorticosterone after oral and parenteral administration. Br. J. Obstet. Gynaecol., 91, 1111-1119.
5. Padwick M., Endacott J., Manson C., Whithead M. (1986) : Adsorption and metabolism of oral progesterone when administered twice daily. Fertil. Steril., 46, 402-407.
6. Nillius S.J., Johansson E.D.B. (1971) : Plasma levels of progesterone after vaginal, rectal or intramuscular administration of progesterone. Am. J. Obstet. Gynecol., 110, 470-477.
7. Fulper L.D., Cleary R.V., Harland E.G., Hilkan A.M., Jones A.B. (1987) : Comparison of serum progesterone levels in dogs after administration of progesterone by vaginal tablet and vaginal suppositories. Am. J. Obstet. Gynecol., 156, 253-259.
8. Chakmakjian Z.H., Zachariah N.Y. (1987) : Bioavailability of progesterone with different modes of administration. J. Reprod. Med., 32, 443-448.
9. Dalton K. (1988) : Treatment of premenstrual syndrome. B.M.J., 297: 490.
10. Hanson W.A. (1982) : Handbook of Dissolution Testing. Springfield, IL: Pharmaceutical Technology.
11. Heinzel G., Woloszczak R., Thomann P. (1993) : Pharmacokinetic and pharmacodynamic data analysis system. Stuttgart: Gustav Fischer.
12. Erny R., Simoncini C., Chastelliere N., de Ligneres B. (1989) : Variations de la progesterone plasmatique induites par l'administration vaginale d'Utrogestan, J. Gynecol. Obstet. Biol. Reprod., 18, 229-234.
13. Simon J.A., Robinson D.E., Andrews M.C. et al. (1993): The absorption of oral micronized progesterone: the effect of food, dose proportionality, and comparison with intramuscular progesterone. Fertil. Steril. 60, 26-33.
14. Archer D.F., Fahy G.E., Viniegra-Sibal A. (1995) : Initial and steady-state pharmacokinetics of a vaginally administered formulation of progesterone. Am. J. Obstet. Gynecol., 173, 471-478.
15. Glazener M.A., Bailay I., Hull M.G.R. (1985) : Effectiveness of vaginal administration of progesterone. Br. J. Obstet. Gynaecol., 92, 364-368.
16. Norman T.R., Morse A.C., Dennerstein L. (1991) : Comparative bioavailability of orally and vaginally administered progesterone. Fertil. Steril., 56, 1034-1039.
17. Maddocks S., Hahn P., Moller F., Reid R.I. (1986) : A double blind placebo-controlled trial of progesterone vaginal suppositories in the treatment of premenstrual syndrome. Am. J. Obstet. Gynecol., 154, 573-581.
18. 14 and its metabolites in the blood after intravenous injections into women. Acta Endocrinol., 51, 563.
19. Glazener M.A., Bailay I., Hull M.G.R. (1985) : Effectiveness of vaginal administration of progesterone. Br. J. Obstet. Gynaecol., 92, 364-368.
20. Mircioiu C., Perju A., Enachescu D., Griu E., Neagu A. (1993) : Biodisposition and pharmacokinetics of percutaneous and intravaginal progesterone. Correlation with in vitro measurements. 3rd Int. Conf. on Prediction Penetration, La Grande Motte, France, 14-16 April, 1993.
21. Mircioiu C. (1994) : Pseudomonocompartmental behaviour of the pharmacokinetics of some topical applied lipophilic drugs. Clin. Trials Meta-Anal., 29, 295.